ghk-cu clinical trial injection FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR GHK-Cu Peptide Injection Before and

At the same time, responsible suppliers and serious labs maintain a clear, consistent message: these are research compounds only, and any use must remain within properly designed studies and legal frameworks

How GHK-Cu Works (in Brief) GHK-Cu acts as a copper-delivery and signaling molecule

At concentrations used in cosmetics (0.1% to 2%), GHK-Cu has a well-documented tolerability record in published studies

Caruso G, Di Pietro L, Cardaci V, Maugeri S, Caraci F

Type 2 diabetes lowers weight loss by about one-third at the same dose: a diabetes trial produced about 10% loss at 2.4 mg versus 15% in non-diabetic obesity